Central endothelin-B receptor stimulation does not affect morphine analgesia in rats

被引:7
作者
Bhalla, S
Matwyshyn, G
Gulati, A
机构
[1] Univ Illinois, Dept Biopharmaceut Sci MC 865, Chicago, IL 60612 USA
[2] Univ Illinois, Dept Bioengn & Neurol & Rehabil Med, Chicago, IL 60612 USA
关键词
morphine analgesia; IRL1620; {Suc-[Glu(9); Ala(11); Ala(15)]ET-1-(8-21)]}; central nervous system; rats; analgesic effect of morphine; opiates; endothelin;
D O I
10.1159/000078628
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Several neurotransmitter mechanisms have been proposed to play a role in the actions of morphine. We reported that centrally administered endothelin A (ETA) receptor antagonists potentiate morphine analgesia in rats. It has also been reported that ETB agonist, IRL1620, has antinociceptive action mediated through opiate receptors in the periphery. The present study was conducted to determine if central ETB receptors are involved in analgesic actions of morphine. The effect of intracerebroventricular (i.c.v.) administration of ETB receptor agonist, IRL1620, on morphine-induced analgesia and hyperthermia was determined in the rat. Morphine (4 mg/kg, s.c.) produced a significant increase (84%) in tail-flick latency compared to the control group and the analgesic response lasted for 4 h. IRL1620 (30 mug, i.c.v.) did not produce any increase (16%) in tail-flick latency over the 5-hour observation period in vehicle-treated rats. Pretreatment with IRL1620 (3, 10, and 30 mug, i.c.v.) did not have any significant effect on the intensity and duration of morphine (4 mg/kg, s.c.)-induced analgesia. Morphine (4 mg/kg, s.c.) administration produced an increase in body temperature compared to the control group. In vehicle-pretreated rats, IRL1620 (30 Ig, i.c.v.) did not produce any change in body temperature. The morphine-induced hyperthermic effect was not altered in IRL1620-pretreated rats. These studies demonstrate that IRL1620, a specific ETB receptor agonist, did not affect the morphine-induced analgesic and hyperthermic effect in rats. It can be concluded that central ETB receptors are not involved in modulation of pharmacological actions of morphine. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:20 / 25
页数:6
相关论文
共 50 条
[41]   Aldosterone Inactivates the Endothelin-B Receptor via a Cysteinyl Thiol Redox Switch to Decrease Pulmonary Endothelial Nitric Oxide Levels and Modulate Pulmonary Arterial Hypertension [J].
Maron, Bradley A. ;
Zhang, Ying-Yi ;
White, Kevin ;
Chan, Stephen Y. ;
Handy, Diane E. ;
Mahoney, Christopher E. ;
Loscalzo, Joseph ;
Leopold, Jane A. .
CIRCULATION, 2012, 126 (08) :963-U163
[42]   Deletion of endothelial cell endothelin B receptors does not affect blood pressure or sensitivity to salt [J].
Bagnall, Alan J. ;
Kelland, Nicholas F. ;
Gulliver-Sloan, Fiona ;
Davenport, Anthony P. ;
Gray, Gillian A. ;
Yanagisawa, Masashi ;
Webb, David J. ;
Kotelevtsev, Yuri V. .
HYPERTENSION, 2006, 48 (02) :286-293
[43]   Spinal effect of the cholecystokinin-B receptor antagonist CI-988 on hyperalgesia, allodynia and morphine-induced analgesia in diabetic and mononeuropathic rats [J].
Coudoré-Civiale, MA ;
Courteix, C ;
Fialip, J ;
Boucher, M ;
Eschalier, A .
PAIN, 2000, 88 (01) :15-22
[44]   CNS STIMULATION DOES NOT AFFECT HEPATIC VENOUS GLUCOSE-CONCENTRATION IN SEVERELY DIABETIC RATS [J].
MIURA, H ;
IGUCHI, A ;
UEMURA, K ;
YATOMI, A ;
TAMAGAWA, T ;
SAKAMOTO, N .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 260 (03) :E440-E446
[45]   Downregulation of Microvascular Endothelial Type B Endothelin Receptor Is a Central Vascular Mechanism in Hypertensive Pregnancy [J].
Mazzuca, Marc Q. ;
Li, Wei ;
Reslan, Ossama M. ;
Yu, Peng ;
Mata, Karina M. ;
Khalil, Raouf A. .
HYPERTENSION, 2014, 64 (03) :632-+
[46]   Deletion of the myeloid endothelin-B receptor confers long-term protection from angiotensin II-mediated kidney, eye and vessel injury [J].
Guyonnet, Lea ;
Czopek, Alicja ;
Farrah, Tariq E. ;
Baudrie, Veronique ;
Bonnin, Philippe ;
Chipont, Anna ;
Lenoir, Olivia ;
Sennlaub, Florian ;
Roubeix, Christophe ;
Webb, David J. ;
Kluth, David C. ;
Bailey, Matthew A. ;
Tharaux, Pierre-Louis ;
Dhaun, Neeraj .
KIDNEY INTERNATIONAL, 2020, 98 (05) :1193-1209
[47]   Endothelin receptor blockade does not affect blood pressure or angiotensin II levels in CYP1A1-Ren-2 transgenic rats with acutely induced hypertension [J].
Vanourkova, Zdenka ;
Kramer, Herbert J. ;
Erbanova, Michaela ;
Baecker, Angela ;
Cervenka, Ludek ;
Huskova, Zuzana ;
Chabova, Vera Certikova ;
Tesar, Vladimir ;
Dvorak, Pavel ;
Maly, Jan ;
Vaneckova, Ivana .
VASCULAR PHARMACOLOGY, 2009, 50 (5-6) :194-199
[48]   Superoxide-dependent hypertension in male and female endothelin B receptor-deficient rats [J].
Sullivan, Jennifer C. ;
Pollock, Jennifer S. ;
Pollock, David M. .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2006, 231 (06) :818-823
[49]   Distinct Alteration in Brain Endothelin A and B Receptor Characteristics Following Focal Cerebral Ischemia in Rats [J].
Bhalla, S. ;
Leonard, M. G. ;
Briyal, S. ;
Gulati, A. .
DRUG RESEARCH, 2016, 66 (04) :189-195
[50]   The endothelin receptor antagonist, L-754,142 does not prevent cyclosporine A-induced osteopenia in rats [J].
Sodam, BR ;
Awumey, EMK ;
Sampson, WH ;
Epstein, S .
CALCIFIED TISSUE INTERNATIONAL, 2001, 68 (02) :117-121